Regulatory miRNAs, circRNAs and lncRNAs in cell cycle progression of breast cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Genetics,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s10142-023-01130-z.pdf
Reference103 articles.
1. Bardhan A, Banerjee A, Basu K, Pal DK, Ghosh A (2022) PRNCR1: a long non-coding RNA with a pivotal oncogenic role in cancer. Hum Genet 141:15–29. https://doi.org/10.1007/s00439-021-02396-8
2. Barnum KJ, O’Connell MJ (2014) Cell cycle regulation by checkpoints. Methods Mol Biol 1170:29–40. https://doi.org/10.1007/978-1-4939-0888-2_2
3. Bida O, Gidoni M, Ideses D, Efroni S, Ginsberg D (2015) A novel mitosis-associated lncRNA, MA-linc1, is required for cell cycle progression and sensitizes cancer cells to Paclitaxel. Oncotarget 6:27880–27890. https://doi.org/10.18632/oncotarget.4944
4. Boon RA, Jae N, Holdt L, Dimmeler S (2016) Long Noncoding RNAs: From Clinical Genetics to Therapeutic Targets? J Am Coll Cardiol 67:1214–1226. https://doi.org/10.1016/j.jacc.2015.12.051
5. Cabili MN, Trapnell C, Goff L, Koziol M, Tazon-Vega B, Regev A, Rinn JL (2011) Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes Dev 25:1915–1927. https://doi.org/10.1101/gad.17446611
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. DROSHA, DICER and Damage-Induced long ncRNA control BMI1-dependent transcriptional repression at DNA double-strand break;2024-08-07
2. Light-activated CRISPR-Cas12a for amplified imaging of microRNA in cell cycle phases at single-cell levels;Science Advances;2024-07-26
3. Integrated analysis of -omic landscapes in breast cancer subtypes;F1000Research;2024-06-03
4. Expression and Significance of LINC02418 in Breast Cancer;Breast Cancer: Targets and Therapy;2024-04
5. MiRNAs as Promising Therapeutic Targets for Breast Cancer;OBM Genetics;2024-02-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3